Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab
-
Published:2024-12
Issue:6
Volume:22
Page:102181
-
ISSN:1558-7673
-
Container-title:Clinical Genitourinary Cancer
-
language:en
-
Short-container-title:Clinical Genitourinary Cancer
Author:
Ornstein Moshe C.ORCID,
George LaethORCID,
Wei WeiORCID,
Diaz-Montero C. Marcela,
Rayman Pat,
Martin Allison,
Basu Arnab,
Beckermann Kathryn E.,
Nizam AmandaORCID,
Wee Christopher E.ORCID,
Gilligan Timothy D.,
Gupta Shilpa,
Rini Brian I.ORCID
Funder
Bristol-Myers Squibb Co